-DOCSTART- -X- O
Age -X- _ O
associated -X- _ O
decline -X- _ O
of -X- _ O
the -X- _ O
immune -X- _ O
system -X- _ O
continues -X- _ O
to -X- _ O
be -X- _ O
a -X- _ O
major -X- _ O
health -X- _ O
concern. -X- _ O
All -X- _ O
components -X- _ O
of -X- _ O
innate -X- _ O
and -X- _ O
adaptive -X- _ O
immunity -X- _ O
are -X- _ O
adversely -X- _ O
affected -X- _ O
to -X- _ O
lesser -X- _ O
or -X- _ O
greater -X- _ O
extent -X- _ O
by -X- _ O
ageing -X- _ O
resulting -X- _ O
in -X- _ O
an -X- _ O
overall -X- _ O
decline -X- _ O
of -X- _ O
immunocompetence. -X- _ O
As -X- _ O
a -X- _ O
result -X- _ O
in -X- _ O
the -X- _ O
aged -X- _ O
population -X- _ O
, -X- _ O
there -X- _ O
is -X- _ O
increased -X- _ O
susceptibility -X- _ O
to -X- _ O
infection -X- _ O
, -X- _ O
poor -X- _ O
responses -X- _ O
to -X- _ O
vaccination -X- _ O
, -X- _ O
and -X- _ O
increased -X- _ O
incidence -X- _ O
of -X- _ O
autoreactivity. -X- _ O
There -X- _ O
is -X- _ O
an -X- _ O
increasing -X- _ O
focus -X- _ O
on -X- _ O
the -X- _ O
role -X- _ O
of -X- _ O
T -X- _ B-Patient
cells -X- _ I-Patient
during -X- _ I-Patient
ageing -X- _ I-Patient
because -X- _ O
of -X- _ O
their -X- _ O
impact -X- _ O
on -X- _ O
the -X- _ O
overall -X- _ O
immune -X- _ O
responses. -X- _ O
A -X- _ O
steady -X- _ B-Outcome
decline -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
production -X- _ I-Outcome
of -X- _ I-Outcome
fresh -X- _ I-Outcome
naïve -X- _ I-Outcome
T -X- _ I-Outcome
cells -X- _ I-Outcome
, -X- _ I-Outcome
more -X- _ I-Outcome
restricted -X- _ I-Outcome
T -X- _ I-Outcome
cell -X- _ I-Outcome
receptor -X- _ I-Outcome
( -X- _ I-Outcome
TCR -X- _ I-Outcome
) -X- _ I-Outcome
repertoire -X- _ I-Outcome
and -X- _ I-Outcome
weak -X- _ I-Outcome
activation -X- _ I-Outcome
of -X- _ I-Outcome
T -X- _ I-Outcome
cells -X- _ I-Outcome
are -X- _ I-Outcome
some -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
effects -X- _ I-Outcome
of -X- _ I-Outcome
ageing. -X- _ I-Outcome
In -X- _ O
this -X- _ O
review -X- _ O
we -X- _ O
summarize -X- _ O
our -X- _ O
present -X- _ O
understanding -X- _ O
of -X- _ O
the -X- _ O
effects -X- _ O
of -X- _ O
ageing -X- _ B-Patient
on -X- _ I-Patient
naïve -X- _ I-Patient
CD4 -X- _ I-Patient
T -X- _ I-Patient
cells -X- _ I-Patient
and -X- _ O
potential -X- _ O
approaches -X- _ O
for -X- _ O
therapeutic -X- _ O
interventions -X- _ O
to -X- _ O
restore -X- _ O
protective -X- _ O
immunity -X- _ O
in -X- _ O
the -X- _ O
aged -X- _ O
population -X- _ O
. -X- _ O

